These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34943191)

  • 21. RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact.
    Vega-Magaña N; Sánchez-Sánchez R; Hernández-Bello J; Venancio-Landeros AA; Peña-Rodríguez M; Vega-Zepeda RA; Galindo-Ornelas B; Díaz-Sánchez M; García-Chagollán M; Macedo-Ojeda G; García-González OP; Muñoz-Valle JF
    Front Cell Infect Microbiol; 2021; 11():672562. PubMed ID: 34123874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H.
    Zeng C; Evans JP; Faraone JN; Qu P; Zheng YM; Saif L; Oltz EM; Lozanski G; Gumina RJ; Liu SL
    mBio; 2021 Oct; 12(5):e0251021. PubMed ID: 34607452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.
    Widera M; Mühlemann B; Corman VM; Toptan T; Beheim-Schwarzbach J; Kohmer N; Schneider J; Berger A; Veith T; Pallas C; Bleicker T; Goetsch U; Tesch J; Gottschalk R; Jones TC; Ciesek S; Drosten C
    Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33918332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b.
    García-García T; Fernández-Rodríguez R; Redondo N; de Lucas-Rius A; Zaldívar-López S; López-Ayllón BD; Suárez-Cárdenas JM; Jiménez-Marín Á; Montoya M; Garrido JJ
    iScience; 2022 Nov; 25(11):105444. PubMed ID: 36310646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14
    Zhou Z; Huang C; Zhou Z; Huang Z; Su L; Kang S; Chen X; Chen Q; He S; Rong X; Xiao F; Chen J; Chen S
    iScience; 2021 Mar; 24(3):102187. PubMed ID: 33615195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.
    Resende PC; Gräf T; Paixão ACD; Appolinario L; Lopes RS; Mendonça ACDF; da Rocha ASB; Motta FC; Neto LGL; Khouri R; de Oliveira CI; Santos-Muccillo P; Bezerra JF; Teixeira DLF; Riediger I; Debur MDC; Ribeiro-Rodrigues R; Leite AB; do Santos CA; Gregianini TS; Fernandes SB; Bernardes AFL; Cavalcanti AC; Miyajima F; Sachhi C; Mattos T; da Costa CF; Delatorre E; Wallau GL; Naveca FG; Bello G; Siqueira MM
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33919314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
    Jangra S; Ye C; Rathnasinghe R; Stadlbauer D; ; Krammer F; Simon V; Martinez-Sobrido L; García-Sastre A; Schotsaert M
    medRxiv; 2021 Jan; ():. PubMed ID: 33532796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
    Villoutreix BO; Calvez V; Marcelin AG; Khatib AM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
    Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
    Front Immunol; 2021; 12():730766. PubMed ID: 34630410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.
    Long SW; Olsen RJ; Christensen PA; Bernard DW; Davis JJ; Shukla M; Nguyen M; Saavedra MO; Yerramilli P; Pruitt L; Subedi S; Kuo HC; Hendrickson H; Eskandari G; Nguyen HAT; Long JH; Kumaraswami M; Goike J; Boutz D; Gollihar J; McLellan JS; Chou CW; Javanmardi K; Finkelstein IJ; Musser JM
    mBio; 2020 Oct; 11(6):. PubMed ID: 33127862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.
    Spratt AN; Kannan SR; Woods LT; Weisman GA; Quinn TP; Lorson CL; Sönnerborg A; Byrareddy SN; Singh K
    Comput Struct Biotechnol J; 2021; 19():3799-3809. PubMed ID: 34188776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
    Isabel S; Graña-Miraglia L; Gutierrez JM; Bundalovic-Torma C; Groves HE; Isabel MR; Eshaghi A; Patel SN; Gubbay JB; Poutanen T; Guttman DS; Poutanen SM
    Sci Rep; 2020 Aug; 10(1):14031. PubMed ID: 32820179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2's pathogenicity factors.
    Baysal Ö; Abdul Ghafoor N; Silme RS; Ignatov AN; Kniazeva V
    PLoS One; 2021; 16(5):e0252571. PubMed ID: 34043733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates.
    Das JK; Sengupta A; Choudhury PP; Roy S
    Gene Rep; 2021 Dec; 25():101044. PubMed ID: 33623833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the mechanisms of SARS-CoV-2 evolution and transmission.
    Chen J; Wang R; Wei GW
    ArXiv; 2021 Sep; ():. PubMed ID: 34545334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.